Yael Capital

Yael Capital (雅亿资本) is a Chinese venture fund that appears repeatedly as a co-investor and follow-on backer in biotech and AI-driven drug discovery deals, per partner fund reporting. It has joined rounds led by 5Y Capital, ZhenFund, and others in companies including Xellar Biosystems, Signet Therapeutics, ReviR Therapeutics, and XtalPi, typically participating at the angel through Series A stages . Its portfolio concentration suggests a focus on life sciences and computational biology rather than a sector-agnostic mandate. Elsewhere's corpus does not carry a standalone profile or founding history for the fund; the above picture is drawn from its presence in deal announcements published by its co-investors.